Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
DarioHealth Corp.

DarioHealth Corp. (DRIO) Stock Overview

Explore DarioHealth Corp.’s financial performance, market position, analyst ratings, and future outlook.

DRIO●NASDAQ
HealthcareMedical - Diagnostics & Research
$7.66
$0.79(11.50%)
U.S. Market opens in 12h 45m

DarioHealth Corp. (DRIO)

Meyka AI Score

Z

Key Financials

Market Cap56M
P/E Ratio2.22
EPS (TTM)$-5.86
ROE0.93%
Fundamental Analysis

AI Price Forecasts

1 Month$8.69
3 Months$20.29
1 Year Target$15.07

DRIO Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of DarioHealth Corp. (NASDAQ: DRIO) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, DarioHealth Corp.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of DRIO on the NASDAQ shows an RSI of 56.11, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $15.07 for the NASDAQ listing.

Key metrics behind DarioHealth Corp.'s NASDAQ-traded stock include a P/E ratio of 2.22 and a market capitalization of 56M. Combined with our AI analysis, these give both institutional and retail investors a clear view of DRIO on the NASDAQ.

Price Performance (NASDAQ: DRIO)

1-Day Change
11.50%
5-Day Change
2.13%
1-Month Change
6.83%
3-Month Change
-4.13%
6-Month Change
-22.63%
Year-to-Date (YTD) Change
-32.69%
1-Year Change
-27.74%
3-Year Change
-88.64%
5-Year Change
-97.39%
All-Time (Max) Change
-99.48%

Contact Information

https://www.dariohealth.com
833 914 3796
18 West 18th Street, New York City, NY, 10011

Company Facts

1,650 Employees
IPO DateMar 14, 2016
CountryUS
Actively Trading

Frequently Asked Questions